IP Library Granted Patent US 11,044,024
Granted Patent B2
US 11,044,024 · App. 16/719,111 · Granted Jun 22, 2021

Communication system with partial power source

Inventors: Mark Zdeblick (Portola Valley, CA); Timothy Robertson (Belmont, CA); Aleksandr Pikelny (Los Angeles, CA); Hooman Hafezi (Redwood City, CA)
Assignee: Proteus Digital Health, Inc.
H04B13/005A61B5/0028A61B5/0031A61B5/07A61B5/073A61B5/076A61B5/1473A61B5/4833A61B5/4839A61B5/6861A61B5/7282A61J3/007G06K7/10168G16H20/10H01Q1/273H04W4/80A61B2560/0214A61B2560/0462A61B2562/08A61B2562/162G06K7/10366Y10T29/49117
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,044,024
App. No.
16/719,111
Granted
Jun 22, 2021
Kind
B2
Abstract

The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.

Claims (20)

1. A composition comprising:

an ingestible component comprising an ingestible event marker and a pharmaceutically acceptable carrier; and

an external layer enclosing the ingestible component to provide a protective barrier for the ingestible component, wherein at least a portion of the external layer is configured to dissolve when the external layer is in contact with a liquid;

wherein the ingestible event marker comprises:

a framework;

a control device coupled to the framework;

a partial power source comprising first and second electrodes formed of dissimilar electrochemical materials configured to contact the liquid and generate a voltage to energize the ingestible event marker; and

a skirt comprised of a non-conducting material surrounding the framework;

wherein the skirt is positioned off-center relative to a central axis of the framework;

wherein the first and second electrodes are deposited on the framework; and

wherein the control device is configured to produce and control a conductive current flow through the liquid to control a conductance between the first and second electrodes and define a unique current signature associated with the ingestible event marker.

2. The composition according to claim 1 , wherein the external layer comprises a homogeneous layer of a single material.

3. The composition according to claim 1 , wherein the external layer comprises two or more distinct materials.

4. The composition according to claim 3 , wherein the two or more distinct materials are present as a multilayer structure.

5. The composition according to claim 1 , wherein the external layer is configured to provide aqueous liquid passage through the external layer upon contact of the composition with the liquid.

6. The composition according to claim 1 , wherein the external layer is configured to protect the ingestible component in a dicing process.

7. The composition according to claim 1 , wherein the external layer is configured to dissolve in five or more minutes upon being in contact with the liquid.

8. The composition according to claim 1 , wherein the external layer is environmentally sensitive.

9. The composition according to claim 8 , wherein the external layer is temperature sensitive.

10. The composition according to claim 8 , wherein the external layer is pH sensitive.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2021
From: PROTEUS DIGITAL HEALTH, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 058244/0543 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2021
From: OTSUKA AMERICA PHARMACEUTICAL, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 058244/0705 →
CHANGE OF NAME Recorded Nov 30, 2021
From: PROTEUS BIOMEDICAL, INC.
To: PROTEUS DIGITAL HEALTH, INC.
Reel/Frame 058287/0719 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2021
From: ZDEBLICK, MARK; ROBERTSON, TIMOTHY; PIKELNY, ALEKSANDR; HAFEZI, HOOMAN
To: PROTEUS BIOMEDICAL, INC.
Reel/Frame 058919/0101 →